Patients with melanoma who reported eating more fiber-rich foods when they began immunotherapy survived longer without cancer growth than patients with insufficient dietary fiber intake, according to research from The University of Texas MD Anderson Cancer Center.
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma.
